Effects of a Two-Year Intensive Multidisciplinary Rehabilitation Program for Patients with Huntington's Disease: a Prospective Intervention Study

• Published in: PLoS currents 2014-11, Vol.6
• Main Authors: Piira, Anu, van Walsem, Marleen R, Mikalsen, Geir, Øie, Lars, Frich, Jan C, Knutsen, Synnove
• Format: Article
• Language: English
• Subjects: Huntington Disease
• ISSN: 2157-3999; 2157-3999
• DOI: 10.1371/currents.hd.2c56ceef7f9f8e239a59ecf2d94cddac

To assess effects of a two year intensive, multidisciplinary rehabilitation program for patients with early- to mid-stage Huntington's disease. A prospective intervention study. One inpatient rehabilitation center in Norway. 10 patients, with early- to mid-stage Huntington's disease. A two year rehabilitation program, consisting of six admissions of three weeks each, and two evaluation stays approximately three months after the third and sixth rehabilitation admission. The program focused on physical exercise, social activities, and group/teaching sessions. Standard measures for motor function, including gait and balance, cognitive function, including MMSE and UHDRS cognitive assessment, anxiety and depression, activities of daily living (ADL), health related quality of life (QoL) and Body Mass Index (BMI). Six out of ten patients completed the full program. Slight, but non-significant, decline was observed for gait and balance from baseline to the evaluation stay after two years. Non-significant improvements were observed in physical QoL, anxiety and depression, and BMI. ADL-function remained stable with no significant decline. None of the cognitive measures showed a significant decline. An analysis of individual cases revealed that four out of the six participants who completed the program sustained or improved their motor function, while motor function declined in two participants. All the six patients who completed the program reported improved or stable QoL throughout the study period. Our findings suggest that participation in an intensive rehabilitation program is well tolerated among motivated patients with early to mid-stage HD. The findings should be interpreted with caution due to the small sample size in this study.